OpenAI announced a strategic investment in Merge Labs, a neurotechnology startup co‑founded by Sam Altman. The company aims to develop non‑invasive brain‑computer interfaces that use ultrasound to read and modulate neural activity. Backed by OpenAI and other investors, Merge Labs plans to combine AI, ultrasound technology, and novel molecular approaches to create accessible, high‑bandwidth interfaces without implanting hardware into brain tissue. The partnership signals OpenAI’s expanding focus on frontier hardware and AI tools that could accelerate progress in brain‑machine communication. Read more →